Respiri Ltd (RSH) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.863x

Based on the latest financial reports, Respiri Ltd (RSH) has a cash flow conversion efficiency ratio of -0.863x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.16 Million ≈ $-2.94 Million USD) by net assets (AU$4.82 Million ≈ $3.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Respiri Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Respiri Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read RSH liabilities breakdown for a breakdown of total debt and financial obligations.

Respiri Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Respiri Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Grande Portage Resources Ltd
V:GPG
-0.011x
Daewoo Elec Co
KO:009320
0.007x
Truong Thanh Furniture Corp
VN:TTF
N/A
Watos Corea Co. Ltd
KQ:079000
0.002x
CESSATECH A/S DK -20
F:8GN
-0.025x
HyosungONBCo.Ltd
KQ:097870
-0.021x
Corline Biomedical AB
ST:CLBIO
-0.029x
Integrated Research Ltd
AU:IRI
0.097x

Annual Cash Flow Conversion Efficiency for Respiri Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Respiri Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Respiri Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-06-30 AU$2.64 Million
≈ $1.87 Million
AU$-6.64 Million
≈ $-4.70 Million
-2.519x +53.62%
2023-06-30 AU$826.89K
≈ $585.08K
AU$-4.49 Million
≈ $-3.18 Million
-5.430x -92.66%
2022-06-30 AU$3.01 Million
≈ $2.13 Million
AU$-8.48 Million
≈ $-6.00 Million
-2.819x -190.73%
2021-06-30 AU$7.57 Million
≈ $5.36 Million
AU$-7.34 Million
≈ $-5.19 Million
-0.969x +48.41%
2020-06-30 AU$2.49 Million
≈ $1.77 Million
AU$-4.69 Million
≈ $-3.32 Million
-1.879x -145.80%
2019-06-30 AU$-1.56 Million
≈ $-1.11 Million
AU$-6.41 Million
≈ $-4.54 Million
4.103x +426.08%
2018-06-30 AU$1.65 Million
≈ $1.17 Million
AU$-2.08 Million
≈ $-1.47 Million
-1.258x +22.74%
2017-06-30 AU$1.80 Million
≈ $1.27 Million
AU$-2.93 Million
≈ $-2.07 Million
-1.629x -175.09%
2016-06-30 AU$4.04 Million
≈ $2.86 Million
AU$-2.39 Million
≈ $-1.69 Million
-0.592x +60.81%
2015-06-30 AU$3.90 Million
≈ $2.76 Million
AU$-5.89 Million
≈ $-4.17 Million
-1.511x -50.70%
2014-06-30 AU$9.08 Million
≈ $6.42 Million
AU$-9.10 Million
≈ $-6.44 Million
-1.002x +67.05%
2013-06-30 AU$1.62 Million
≈ $1.15 Million
AU$-4.94 Million
≈ $-3.49 Million
-3.042x -31.80%
2012-06-30 AU$2.11 Million
≈ $1.50 Million
AU$-4.88 Million
≈ $-3.45 Million
-2.308x +9.05%
2011-06-30 AU$2.11 Million
≈ $1.49 Million
AU$-5.35 Million
≈ $-3.79 Million
-2.538x -42.04%
2010-06-30 AU$2.87 Million
≈ $2.03 Million
AU$-5.12 Million
≈ $-3.62 Million
-1.787x -100.81%
2009-06-30 AU$3.93 Million
≈ $2.78 Million
AU$-3.50 Million
≈ $-2.47 Million
-0.890x +25.57%
2008-06-30 AU$4.85 Million
≈ $3.43 Million
AU$-5.80 Million
≈ $-4.10 Million
-1.195x -25.66%
2007-06-30 AU$2.41 Million
≈ $1.70 Million
AU$-2.29 Million
≈ $-1.62 Million
-0.951x +43.74%
2006-06-30 AU$388.37K
≈ $274.80K
AU$-656.61K
≈ $-464.60K
-1.691x -220.00%
2005-06-30 AU$1.51 Million
≈ $1.07 Million
AU$-798.42K
≈ $-564.93K
-0.528x +2.81%
2004-06-30 AU$1.14 Million
≈ $808.22K
AU$-620.94K
≈ $-439.36K
-0.544x +93.29%
2002-06-30 AU$1.38 Million
≈ $976.29K
AU$-11.18 Million
≈ $-7.91 Million
-8.103x -1073.26%
2001-06-30 AU$13.28 Million
≈ $9.40 Million
AU$-9.17 Million
≈ $-6.49 Million
-0.691x --

About Respiri Ltd

AU:RSH Australia Medical Devices
Market Cap
$39.01 Million
AU$55.13 Million AUD
Market Cap Rank
#22758 Global
#862 in Australia
Share Price
AU$0.04
Change (1 day)
+0.00%
52-Week Range
AU$0.04 - AU$0.05
All Time High
AU$0.24
About

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limi… Read more